Tyrosine Kinase Inhibitors (TKIs) - Imatinib (Gleevec) - Pharmacology - CML and ALL Medicosis Perfectionalis 4:20 5 years ago 89 433 Скачать Далее
The future of tyrosine kinase inhibitors for melanoma and open questions VJOncology 2:23 7 years ago 340 Скачать Далее
Mechanisms of TKI resistance European Society for Medical Oncology (ESMO) 4:44 6 years ago 5 811 Скачать Далее
HCC Whiteboard #3: The Management of Adverse Events of Tyrosine Kinase Inhibitors HMP Education 3:12 6 years ago 2 307 Скачать Далее
"TKIs: Tyrosine Kinase Inhibitors & Neuroendocrine Tumors" • 2024 LACNETS Event • March 29, 2024 LACNETS 1:18:47 4 months ago 589 Скачать Далее
Webinar Wednesdays - Tyrosine kinase inhibitors & PKD PKDFoundation 1:00:31 3 years ago 460 Скачать Далее
The Role of Tyrosine Kinase Inhibitors and mTOR Inhibitors Kidney Cancer 41:21 9 years ago 4 276 Скачать Далее
TKI and checkpoint inhibitor combinations for kidney cancer: the IMmotion151 trial VJOncology 2:02 6 years ago 139 Скачать Далее
Second-generation tyrosine kinase inhibitors for chronic myeloid leukemia VJHemOnc – Video Journal of Hematology & HemOnc 3:12 9 years ago 630 Скачать Далее
Selecting EGFR Tyrosine Kinase Inhibitors for EGFR-Mutant Lung Cancer Targeted Oncology 0:52 4 years ago 438 Скачать Далее
FGFR-Specific TKIs Versus Multikinase Inhibitors Targeted Oncology 3:50 5 years ago 136 Скачать Далее
Management of Thrombosis Risk with Ponatinib and other TKIs for CML? HMP Education 24:30 9 years ago 1 202 Скачать Далее
Optimizing discontinuation of tyrosine kinase inhibitor treatment for chronic myeloid leukemia VJHemOnc – Video Journal of Hematology & HemOnc 4:33 9 years ago 478 Скачать Далее
Combining autophagy inhibitors with TKIs in CML VJHemOnc – Video Journal of Hematology & HemOnc 1:04 1 year ago 96 Скачать Далее
Selecting a Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia Case Study OncLive 9:08 8 years ago 925 Скачать Далее
